CHINA CBM (08270) announces a positive earnings forecast, expecting a net profit of approximately 70 to 80 million yuan for the interim period.
China Coalbed Methane (08270) announced that the group expects to achieve a net profit not less than RMB 70 million and not exceeding RMB 80 million for the six months ending June 30, 2026, while the preceding six months ending June 30, 2025, are expected to record a net loss. The anticipated turnaround to profitability for the six months ending June 30, 2026, is mainly due to a one-time gain of approximately RMB 75 million from the sale of a subsidiary during the period.
CHINA CBM (08270) announced that the group expects to achieve a net profit of not less than RMB 70 million and not more than RMB 80 million for the six months ending June 30, 2026, while it incurred a net loss for the six months ending June 30, 2025. The anticipated turnaround to profitability for the six months ending June 30, 2026, is mainly due to a one-time gain of approximately RMB 75 million generated from the sale of a subsidiary during the period.
Related Articles

After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).

RECOMMEND





